With the Trump administration's drastic cuts to foreign aid, tuberculosis (TB) patients, such as 40-year-old Dalvin Modore from Kenya, face a grim reality of deteriorating health and increased risk of disease spread, as international funding for vital health programs dwindles.
Tuberculosis Crisis Deepens as U.S. Funding Cuts Leave Patients Vulnerable

Tuberculosis Crisis Deepens as U.S. Funding Cuts Leave Patients Vulnerable
The abrupt withdrawal of U.S. funding for tuberculosis programs has led to a resurgence of the disease in several countries, leaving countless individuals without essential treatment options.
The situation surrounding tuberculosis (TB) treatment worldwide has reached critical levels following the Trump administration’s significant funding cuts to foreign aid. The U.S., which once contributed roughly half of the international funding for TB programs, has seen countless patients, like Dalvin Modore from western Kenya, suffer tremendously due to diminished access to testing and treatment.
Dalvin, at 40 years old, is weighed down not only by the disease that has left him with a persistent cough and rapid weight loss but also by the emotional toll of uncertainty about his future. With his weight plummeting to just 110 pounds and symptoms worsening, he symbolizes the plight of many who are left without the lifesaving care they need.
The discontinuation of funding effectively dismantled the infrastructure that was crucial for diagnosing and treating TB, especially in regions with the highest infection rates. As patients like Dalvin wait for medication and aid that may never arrive, they inadvertently expose others to the disease, escalating the risk of outbreaks within communities.
Since President Trump's orders for the aid freeze on Inauguration Day, the response to TB in numerous African and Asian countries has significantly deteriorated. The resources provided by U.S. aid were pivotal, covering everything from laboratory equipment to staffing—resources that are now severely lacking. Trump administration officials have justified the cuts by insisting that foreign nations should be more assertive in their funding responsibilities, leaving a dangerously thin safety net for global health initiatives.
Without the necessary support and intervention, the gains made against tuberculosis over the years are at risk of being eroded, compounding a public health crisis that could reverberate far beyond the countries most affected.